The General Data Protection Regulations that came into force on April 27, 2016 constitutes the reference text in terms of personal data protection (DCP). It strengthens and unifies data protection for individuals within the European Union.
Designated as binding, the GDPR implies heavy change in the management of DCPs of its employees, patients or customers, in fact the GDPR applies to all types of hospitals, companies, laboratories ... (apart from legal bodies).
Application and respect for the GDPR has therefore become:
- A guarantee of trust for employees of a company
- An asset to keep your business
- An advantage to conquer a market
The objective of this expert webinar will be to make the General Data Protection Regulations (RGDP) an asset for your business!
Reflections will be carried out on the valuation of this compliance as an internal asset to reassure your employees regarding the security of their personal data (DCP), and external as a sale of sales with your customers and your partners.
In order to enlighten us on this theme, we invite you to approach the main lines of the GDPR, which it implies within an innovative company, as well as the consequences of non -compliance with its requirements.
The point of view of Mr. Bertrand Poulnot and his solutions will be shared.
The program will take place as follows:
- 10:00 am: opening word
- GDPR: Risks and solutions – M. Bertrand POULNOT – CEO – Poulnot Courtage
- The GDPR: where how to go from a constraint to a competitive advantage – M. Fabien Crozet - President - DPO Consulting
- Back of experiences from innovative companies:
- REEV – M. Amaury Ciurana – CEO & Co-founder
- GDPR strategy and the actions implemented in progress and to come
- Compliance of patient data/DCP
- The GDPR route: stages, deadlines, costs ...
- Discussion on testimony, answers to questions and introduction of the subject of clinical trials
- Medes Pharma– Mrs Elodie Foujols – Responsable relations institutionnelles & DPO
- Compliance of the clinical trial vis-à-vis the GDPR: upstream phase and during the trial
- Pitfalls
- The course: steps, deadlines, costs ...
- Discussion on testimony, answers to questions
- REEV – M. Amaury Ciurana – CEO & Co-founder
- Opening on the GDPR considered as a native criterion of AAPS. – Mr. Fabien Crozet - President - DPO Consulting
- Questions/Answers
- 12 noon: fence
INSCRIPTION FREE MORE MANDATORY, Before 08/12/2022
Inscriptions : Online form
With the support of :
Webinar reserved for Eurobiomed members.
For more information:
Jeoffrey Tagliamonte
Competitiveness and DPO mission manager
jeoffrey.tagliamonte@eurobiomed.org